J. Biol. Chem., Vol. 261, Issue 25, 11456-11459, Sep, 1986
Inhibitory action of forskolin on adenylate cyclase activity and cyclic AMP generation [published erratum appears in J Biol Chem 1987 Jan 25;262(3):1425]
A Khanum and ML Dufau
In testicular Leydig cells, forskolin causes the expected stimulation of
cAMP and testosterone production and potentiates gonadotropin- induced
responses, when present in concentrations of 1-10 microM. In addition, when
added at lower doses that did not affect cAMP generation and testosterone
responses (100 nM), forskolin caused an increase in sensitivity to hormonal
stimulation for all cAMP pools (extracellular, intracellular, and
receptor-bound) and a 70% reduction in the ED50 for human chorionic
gonadotropin (hCG) stimulation of testosterone production.
Forskolin-induced increases in receptor-bound cAMP were less effective than
those elicited by hCG in stimulating steroidogenesis. In contrast to the
well-known stimulatory actions of forskolin, low doses of the diterpene (in
the picomolar to nanomolar range) markedly inhibited the production of cAMP
and testosterone. Such inhibitory actions of low-dose forskolin were
prevented by preincubation of Leydig cells with pertussis toxin before
addition of forskolin and/or hCG. Low concentrations of forskolin also
inhibited adenylate cyclase activation by GTP and luteinizing hormone, and
this effect was prevented by pretreatment of cell membranes with pertussis
toxin. These studies have defined the stimulatory effects of forskolin on
Leydig-cell cAMP pools, including potentiation of the hormonal increase in
receptor-bound cyclic AMP by forskolin, and have provided additional
evidence for the functional importance of cAMP compartmentalization during
hormonal stimulation of steroidogenesis. We have also demonstrated a novel,
high-affinity inhibitory action of forskolin upon adenylate cyclase
activity and cyclic AMP generation, an effect that appears to be mediated
by the Ni guanine nucleotide regulatory subunit of adenylate cyclase.